🔎 Trials Near Me

Akèy › Kansè san › Utah › Salt Lake City

Etid klinik pou Kansè san nan Salt Lake City, UT

8 etid pou Kansè san ap chèche patisipan nan sit nan ak bò kote Salt Lake City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Ap rekriteFaz 2
  • Huntsman Cancer Institute - University of Utah Health, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • University of Utah, Salt Lake City
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

Ap rekriteEtid obsèvasyon
  • Primary Children's Hospital, Salt Lake City
Jiska laj 30 · Tout sèks · Mizajou Jun 18, 2026 · NCT06579469

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Ap rekriteEtid obsèvasyon
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT05663502

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Ap rekriteFaz 1
  • University of Utah, Salt Lake City
Laj 13 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT04771572

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Ap rekriteFaz 3
  • Primary Children's Hospital, Salt Lake City
Laj 2 a 18 · Tout sèks · Mizajou May 5, 2026 · NCT05711667

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Ap rekriteFaz 1/2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Primary Children's Hospital, Salt Lake City
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Kansè san nan lòt vil

Lòt etid nan Salt Lake City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.